Literature DB >> 21886654

Rare case of "red man" syndrome in a female patient treated with oral vancomycin for Clostridium difficile diarrhoea.

Mani Nallasivan1, Fergus Maher, Krishna Murthy.   

Abstract

A 58-year-old Caucasian woman was admitted for knee replacement but during the postoperative period she developed sepsis due to pneumonia, which was treated with coamoxiclav and then piperacillin (for 2 weeks). She had renal failure, which needed haemofiltration. During her recovery she had diarrhoea due to Clostridium difficile, which was not controlled with metronidazole. Vancomycin was therefore given, but she developed urticarial erythematous skin rash and hence it was stopped. She was not on any other new medications and a vasculitic screen was negative. A dermatologist reviewed her file as well. The skin rash subsided after 2 weeks with topical emollients and chlorphenamine tablets. Her diarrhoea eventually settled and she went home well. Though classically described in men, this "red man" syndrome (features of urticarial erythematous rash due to oral vancomycin) has been previously reported in case reports and in literature reviews.

Entities:  

Year:  2009        PMID: 21886654      PMCID: PMC3029619          DOI: 10.1136/bcr.03.2009.1705

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

Review 1.  Oral vancomycin-induced rash: case report and review of the literature.

Authors:  J M McCullough; D G Dielman; D Peery
Journal:  DICP       Date:  1991-12

2.  An elderly woman with 'Red Man Syndrome' in association with oral vancomycin therapy: a case report.

Authors:  Phillippa Bailey; Henry Gray
Journal:  Cases J       Date:  2008-08-18
  2 in total
  2 in total

Review 1.  Does oral vancomycin use necessitate therapeutic drug monitoring?

Authors:  Nevio Cimolai
Journal:  Infection       Date:  2019-11-11       Impact factor: 3.553

2.  Rash induced by enteral vancomycin therapy in an older patient in a long-term care ventilator unit: case report and review of the literature.

Authors:  Jeremy Barron; Adolfo Lattes; Esther-Lee Marcus
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-06       Impact factor: 3.406

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.